Römer T, Müller J, Bojahr B, Schwesinger G, Lober R
Klinik für Frauenheilkunde und Geburtshilfe, Ernst-Moritz-Arndt-Universität Greifswald.
Zentralbl Gynakol. 1996;118(5):291-4.
In a prospective study in 40 patients the pretreatment for endometrial ablation with a gestagen (Orgametril 10 mg/die), danazol (600 mg/die) and an injection of a GnRH-analogon (Decapeptyl-Depot) was compared with a control group without pretreatment. The subjective estimation of the surgeon (endometrial thickness and depth of coagulation) showed a sufficient pretreatment in 90 % of all cases following danazol- and GnRH-analogon-pretreatment. In 90 % of the danazol- and GnRH-analogon pretreated group the histological findings showed also an atrophic or little proliferative endometrium. In a follow up of 6 months after endometrial ablation the highest amenorrhoea-rates were reached following danazol- and GnRH-analogon pretreatment. These two regimes should be used for the pretreatment for endometrial ablation.
在一项针对40例患者的前瞻性研究中,将使用孕激素(甲地孕酮10毫克/日)、达那唑(600毫克/日)和注射促性腺激素释放激素类似物(曲普瑞林长效注射剂)进行子宫内膜消融术前预处理的情况与未进行预处理的对照组进行了比较。外科医生的主观评估(子宫内膜厚度和凝固深度)显示,在所有接受达那唑和促性腺激素释放激素类似物预处理的病例中,90%的病例预处理效果良好。在90%接受达那唑和促性腺激素释放激素类似物预处理的组中,组织学检查结果也显示子宫内膜呈萎缩性或轻度增生性。在子宫内膜消融术后6个月的随访中,达那唑和促性腺激素释放激素类似物预处理后的闭经率最高。这两种方案应用于子宫内膜消融术前预处理。